United States Kyphoplasty Market Size, Share, and COVID-19 Impact Analysis, By Product (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing Systems, and Instruments), By Application (Vertebral Alignment Restoration, Spinal Fractures, and Kyphosis), and United States Kyphoplasty Market Insights, Industry Trend, Forecasts to 2035

United States Kyphoplasty Market Insights Forecasts to 2035

• The US Kyphoplasty Market Size Was Estimated at USD 276.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.91% from 2025 to 2035
• The US Kyphoplasty Market Size is Expected to Reach USD 469.1 Million by 2035

According to a research report published by Spherical Insights & Consulting, The United States Kyphoplasty Market Size is anticipated to reach USD 469.1 Million by 2035, growing at a CAGR of 4.91% from 2025 to 2035. The expansion of the United States kyphoplasty market is propelled by the ageing population's growing base and the rising incidence.

Market Overview

Kyphoplasty is a minimally invasive surgical technique used to treat vertebral compression fractures, which are frequently brought on by spinal injuries, tumours, or osteoporosis. According to the National Library of Medicine, there are expected to be between 1 and 1.5 million VCFs in the United States annually. 25% of women over 50 reports having at least one VCF, even after controlling for age and gender. There is even an estimated 40 to 50 percent of persons over the age of 80 who have either had a VCF acutely or been diagnosed with a VCF incidentally while being treated for another disease. Compared to traditional non-surgical treatment, vertebral augmentation techniques like balloon kyphoplasty have reduced mortality rates by up to 55%. The continually growing rates of osteoporosis and vertebral compression fracture cases are the driving force behind the market. The rising rates of osteoporosis, especially in senior citizens, are creating a greater need for kyphoplasty procedures. Another large factor that is increasing growth is the changing demand for less invasive procedures. Compared to open surgery, kyphoplasty is less invasive with smaller incisions, less pain, less scarring, and shorter recovery periods. The market is also increasing due to growing awareness of VCF diagnosis.  Many patients may not know they have VCF, and VCF could be hard to diagnose.

Report Coverage

This research report categorizes the market for the United States kyphoplasty market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States kyphoplasty market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States kyphoplasty market.

Driving Factors

The growth of the United States kyphoplasty market is boosted by the rising incidence of osteoporosis, advances and developments in technology, expanding applications, and evolving regulations within the healthcare field that encourage minimally invasive procedures. The most significant driver in the kyphoplasty market is the increasing elderly population, who are at greater risk for skeletal and spinal fractures due to loss of bone mass. With the increasing life expectancy, the demand for reliable fracture care methods is escalating, which is making kyphoplasty a viable option. Advancements in biomaterials, including next-generation bone cements with increased biocompatibility and durability, are bolstering kyphoplasty procedure success, while the development is inspiring an increased number of surgeons to use this treatment.

Restraining Factors

The United States kyphoplasty market faces obstacles like the high procedural costs, ranging from $8,000 to $16,000 per treatment, which are preventing patients from accessing kyphoplasty. Variability in insurance coverage, inconsistency in reimbursement, and difficult medical necessity verification present barriers to adoption.

Market Segmentation

The United States kyphoplasty market share is classified into product and application.

• The bone access devices segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States kyphoplasty market is segmented by product into balloon catheters, bone access devices, cement application products, bone cement, cement mixing systems, and instruments. Among these, the bone access devices segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven by IZI medical products released Vertefix HV cement due to the need for real-time flow evidence during cement injections in kyphoplasty and vertebroplasty procedures. With its introduction, the company intended to give physicians a better way to observe and monitor the flow of cement throughout the procedure.

• The spinal fractures segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the application, the United States Kyphoplasty market is segmented into vertebral alignment restoration, spinal fractures, and kyphosis. Among these, the spinal fractures segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled by the recent rise in occurrences of compressed spine bones due to trauma and cancer. This is a greater issue because kyphoplasty procedures are predominant in treating this condition. The market is growing due to an increase in cases of compressed spine bones.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States kyphoplasty market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Joimax
• Merit Medical Systems Inc
• CareFusion
• Stryker Corp
• Johnson & Johnson
• Medtronic plc
• Globus Medical
• Benvenue Medical
• Cook Medical
• Cardinal Health
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States kyphoplasty market based on the following segments:

United States Kyphoplasty Market, By Product

• Balloon Catheters
• Bone Access Devices
• Cement Application Products
• Bone Cement
• Cement Mixing Systems
• Instruments

United States Kyphoplasty Market, By Application

• Vertebral Alignment Restoration
• Spinal Fractures
• Kyphosis